TOK 8801;Imidazo[2,1-b]thiazole-2-carboxamide, 5,6-dihydro-3,6,6-trimethyl-N-(2-phenylethyl)-;TOK 8801,TOK8801;3,6,6-trimethyl-N-(2-phenylethyl)-5H,6H-imidazo[2,1-b][1,3]thiazole-2-carboxamide
TOK-8801 is under development as an immunomodulator; it enhances the in vitro anti-SRBC plaque-forming cell (PFC) response of murine splenocytes in a bell-shaped manner; it restores the restraint stress-impaired anti-SRBC PFC response in vivo; it suppresses the delayed-type hypersensitivity (DTH) reaction in high responders.